课题基金 / 基金详情

The influence of human gut bacteria on bioavailability of flavonoids (Consortium: Flavonoids and polyphenols)

The influence of human gut bacteria on bioavailability of flavonoids (Consortium: Flavonoids and polyphenols)
人类肠道细菌对类黄酮生物利用度的影响(联盟:类黄酮和多酚)
批准号:
5400624
负责人:
Dr. Annett Braune
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2003
资助国家:
德国
项目状态:
已结题
起止时间:
2002-12-31 至 2005-12-31

项目摘要

项目成果

Dr. Annett Braune的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed project is aimed to elucidate the role of the gut microbiota in the conversion of selected dietary flavonoids and to investigate how and to which extent intestinal bacteria influence their. The data expected to emerge from the project are of relevance to safety issues as related to the oral intake of flavonoids. Since human subjects with a germ-free (GF) status are not available, GF rats and rats associated with human gut bacteria (HFA rats) will serve as models. Selected compounds representing flavones, anthocyanidins and prenylated flavonoids will be fed to these rats. Subsequently, blood, urine and feces will be collected from these animals and analyzed by HPLC, GC and LC-MS techniques for the applied substances and their degradation products. The comparison of GF and HFA rats will indicate whether and to which extent intestinal bacteria transform the ingested compounds. The products of the bacterial conversions will be identified and their absorption in the gastrointestinal tract of the animals be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Charakterisierung von Isoflavon-umsetzenden Enzymen aus Darmbakterien des Menschen
The role of human gut bacteria in bioactivation of polyphenolic isoflavones and pyranoanthocyanins
国内基金
海外基金
靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡文静
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
自闭症相关基因CHD8在非人灵长类大脑发育中的作用
HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
  • 批准号:
    81960115
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2019
  • 负责人:
    江建宁
  • 依托单位: